Stay updated on CM-24 Combo Study With Pembrolizumab Clinical Trial

Sign up to get notified when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the CM-24 Combo Study With Pembrolizumab Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    The study record content remains the same; only minor layout changes are visible. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-10-30T11:19:19.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    33 days ago
    Change Detected
    Summary
    Adds v3.2.0 and removes a specific disease resource (Ovarian cancer); minor content scope change and update history.
    Difference
    0.4%
    Check dated 2025-10-01T03:52:03.000Z thumbnail image
  4. Check
    34 days ago
    Change Detected
    Summary
    Added v3.1.0 revision; removed Ovarian cancer resource under Genetic and Rare Diseases Information Center; removed older v3.0.2 revision.
    Difference
    0.4%
    Check dated 2025-09-30T02:55:39.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page updates from v3.0.1 to v3.0.2, and the 'Back to Top' link was removed. No substantive changes to core content or critical data are indicated.
    Difference
    0.2%
    Check dated 2025-09-15T19:28:44.000Z thumbnail image
  6. Check
    56 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. Additionally, a 'Back to Top' feature has been added for improved navigation.
    Difference
    0.2%
    Check dated 2025-09-08T15:04:46.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    The web page has undergone significant updates, including the addition of new cancer-related topics and resources, as well as the introduction of a facility name and location in Hod HaSharon, Israel. However, several previous entries, including specific cancer types and resources, have been removed.
    Difference
    7%
    Check dated 2025-09-01T09:45:14.000Z thumbnail image

Stay in the know with updates to CM-24 Combo Study With Pembrolizumab Clinical Trial

Enter your email address, and we'll notify you when there's something new on the CM-24 Combo Study With Pembrolizumab Clinical Trial page.